2015
DOI: 10.1152/ajpgi.00172.2014
|View full text |Cite
|
Sign up to set email alerts
|

TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow

Abstract: The trefoil factor TFF2 is a member of a tripartite family of small proteins that is produced by the stomach and the colon. Recombinant TFF2, when applied intrarectally in a rodent model of hapten colitis, hastens mucosal healing and reduces inflammatory indexes. Additionally, TFF2 is expressed in immune organs, supporting a potential immunomodulatory and reparative role in the bowel. In this study we confirm that TFF2 is expressed in the colon and is specifically enriched in epithelial cells relative to colon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
30
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(32 citation statements)
references
References 60 publications
(61 reference statements)
2
30
0
Order By: Relevance
“…TFF2 reduces colonic inflammation by inhibiting NO production derived from iNOS in monocytes (148). Following DSS-induced colitis, Tff2 KO mice, but not Tff1 KO mice, show severe weight loss accompanied with an altered inflammatory cytokine expression profile, such as further upregulation of Il-6 and downregulation of Il-33, when compared with WT mice (149). Interestingly, the peritoneal macrophages from Tff2 KO mice show downregulation of Il-6 , Il-1β , Il-10 , Il-19 , and Il-33 compared to WT mice.…”
Section: Trefoil Factor and Gastrointestinal Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…TFF2 reduces colonic inflammation by inhibiting NO production derived from iNOS in monocytes (148). Following DSS-induced colitis, Tff2 KO mice, but not Tff1 KO mice, show severe weight loss accompanied with an altered inflammatory cytokine expression profile, such as further upregulation of Il-6 and downregulation of Il-33, when compared with WT mice (149). Interestingly, the peritoneal macrophages from Tff2 KO mice show downregulation of Il-6 , Il-1β , Il-10 , Il-19 , and Il-33 compared to WT mice.…”
Section: Trefoil Factor and Gastrointestinal Diseasesmentioning
confidence: 99%
“…Interestingly, the peritoneal macrophages from Tff2 KO mice show downregulation of Il-6 , Il-1β , Il-10 , Il-19 , and Il-33 compared to WT mice. Additionally, LPS stimulation enhanced an increase of Il-6 and Il-1β production and reduced levels of Il-10 and Il-19 production, whereas Il-33 sustained a low level in the peritoneal macrophages from Tff2 KO mice (149). As TFF3 expression is altered in the Tff2 KO mice, it is possible that some of these effects are mediated by TFF3.…”
Section: Trefoil Factor and Gastrointestinal Diseasesmentioning
confidence: 99%
“…2B). Although, a possibility that immune modulation by Tff2 would participate on tumor development as reported [19], Tff2, at last, could enlarge tumor size independently from immune response, because the xenograft experiment in our present study used nude mice which deficient in immune system (Fig. 2C).…”
Section: Discussionmentioning
confidence: 67%
“…The above-described findings might be supported by the colon histology results showing that the status of the goblet cells damaged by DSS was alleviated in the DHY8 mice compared to the DSS mice. In addition, TFF2 deficiency has been reported to lead to a loss of body weight [33], and the upregulation of TFF2 induced by HY supplementation seems consistent with improved body weight loss.…”
Section: Discussionmentioning
confidence: 98%
“…The downregulation of Egfr by HY supplementation indicates the improvement of colitic status. Tff2 , which is secreted and expressed by gastrointestinal epithelium and plays a vital role in the maintenance of epithelial integrity and mucosal surfaces [33], was upregulated by HY supplementation. Moreover, Tff2 is essential in the immune response in inflammatory conditions by controlling the expression of pro-inflammatory cytokines such as IL6 and IL1β [34].…”
Section: Discussionmentioning
confidence: 99%